查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
患者選配AI臨床試驗解決方案的全球市場(2022年～2030年):市場佔有率，規模，趨勢，產業分析，各治療用途，各最終用途，各地區，各市場區隔預測
市場調查報告書
商品編碼
1175497

患者選配AI臨床試驗解決方案的全球市場(2022年～2030年):市場佔有率，規模，趨勢，產業分析，各治療用途，各最終用途，各地區，各市場區隔預測

AI-based Clinical Trial Solutions For Patient Matching Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Application; By End-Use (Pharmaceutical Companies, Academia, Others); By Region; Segment Forecast, 2022 - 2030
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

全球患者選配AI臨床試驗解決方案的市場規模，預計至2030年成為19億6,900萬美元。

本報告提供全球患者選配AI臨床試驗解決方案市場調查，市場概要，市場的推動因素與阻礙因素的分析，市場機會，COVID-19影響，各市場區隔的市場分析，競爭情形，主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 關於報告
    • 調查目的
    • 市場範圍
    • 前提條件
  • 利害關係者

第2章 摘要整理

  • 市場概況

第3章 調查手法

  • 概要
    • 資料探勘
  • 資料資訊來源
    • 一級資訊來源
    • 二級資訊來源

第4章 全球患者選配AI臨床試驗解決方案市場:洞察

  • 產業的概述
  • 市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 波特的五力分析
    • 供給企業談判力(中)
    • 新加入廠商的威脅(低)
    • 買方議價能力(中)
    • 替代威脅(中)
    • 現有企業間的競爭(高)
  • 大環境分析
  • 產業趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球患者選配AI臨床試驗解決方案市場:各治療用途

  • 主要調查結果
  • 簡介
    • 各治療用途的全球市場(2018年～2030年)
  • 腫瘤
    • 腫瘤，各地區
  • 心血管疾病
    • 心血管疾病，各地區
  • 代謝疾病
    • 代謝疾病，各地區
  • 神經疾病、症狀
    • 神經疾病、症狀，各地區
  • 感染疾病
    • 感染疾病，各地區
  • 其他
    • 其他，各地區

第6章 全球患者選配AI臨床試驗解決方案市場:各最終用途

  • 主要調查結果
  • 簡介
    • 各最終用途全球市場(2018年～2030年)
  • 製藥公司
    • 各製藥廠，各地區
  • 學界
    • 學界，各地區
  • 其他
    • 其他，各地區

第7章 全球患者選配AI臨床試驗解決方案市場:各地區

  • 主要調查結果
  • 簡介
    • 患者選配AI臨床試驗解決方案市場的評估:各地區(2018年～2030年)
  • 北美
    • 各最終用途
    • 各治療用途
    • 美國
    • 加拿大
  • 歐洲
    • 各最終用途
    • 各治療用途
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 各最終用途
    • 各治療用途
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東、非洲
    • 各最終用途
    • 各治療用途
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 南美
    • 各最終用途
    • 各治療用途
    • 墨西哥
    • 巴西
    • 阿根廷

第8章 競爭情形

  • 擴張和收購的分析
    • 擴張
    • 收購
  • 夥伴關係/合作/協定/展示會

第9章 企業簡介

  • Unlearn.AI, Inc
  • Antidote Technologies;Inc
  • Deep6.ai
  • Mendel.ai
  • Aris Global
  • Deep Lens
  • AmerisourceBergen Corporation
  • Koneksa
  • Microsoft Corporation
  • GNS Healthcare
Product Code: PM2727

The global ai-based clinical trial solutions for patient matching market size is expected to reach USD 1,969 million by 2030, according to a new study by Polaris Market Research. The report "AI-based Clinical Trial Solutions For Patient Matching Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Application; By End-Use (Pharmaceutical Companies, Academia, Others); By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

With the dominance of branded products and the rising prevalence of diseases in the region, North America dominated the market in terms of revenue in 2021. Because of increased government and corporate investment in AI-based technologies to achieve higher efficiency and improve operational processes, as well as increased use of advanced technologies such as Artificial Intelligence (AI), Machine Learning (ML), and deep learning in clinical trials, the North America region dominates the global market share.

The United States is a significant contributor to the North American region. Other factors expected to contribute to the country's market growth include the presence of biopharmaceutical companies and ongoing oncology research to develop therapeutic drugs. In 2023, there will be approximately 37.3 million diabetics in the United States, including 28.7 million instances that have been diagnosed and 8.5 million cases that have not.

Europe is the second-largest market for AI-based Clinical Trials Solution Providers, trailed by the ASEAN region. Due to factors like growing geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of governmental and nonprofit organizations in the market space, Asia Pacific is predicted to experience significant growth during the forecast period.

Traditional R&D processes are time-consuming, costly, and require significant investment. Because of the high development costs, pharmaceutical and biotech companies are increasingly incorporating artificial intelligence (AI) into their research and development efforts in order to reduce costs, improve data quality, and shorten trial lengths.

Artificial intelligence (AI) and machine learning techniques are gradually improving clinical trial efficiencies, streamlining clinical practice processes, and enabling pharmaceutical companies to discover novel treatments and therapies more quickly and cost-effectively. This is expected to drive significant future growth in the global market.

An increase in the number of clinical studies, as well as increased government and private efforts to improve healthcare facilities through the adoption of novel AI technology and drugs, are driving market revenue growth.

Growing awareness of the benefits of AI-based clinical trials is expected to drive market revenue growth over the forecast period. Furthermore, wearable technology, in conjunction with AI techniques, is useful in real-time, individualized, and continuous monitoring of patients during trials. This can improve patient adherence to the protocol and the accuracy of the endpoint assessment.

Increasing the number of strategic alliances in the deployment of Artificial Intelligence (AI) in clinical trials in order to reduce time and expenditure during clinical development phases is expected to result in profitable market growth shortly.

Furthermore, regulators worldwide have issued guidelines encouraging biopharma companies to use real-world evidence strategies. For example, in 2019, the US FDA passed the 21st Century Cures Act, intended to help bring new innovations and advances to patients more efficiently and quickly. By providing faster insights to form decisions, using AI in clinical trials saves time and money. AI assists investigators in answering some questions, such as how to construct study designs, identify sites and patients for clinical research, and digitize adverse drug reactions.

AI-based Clinical Trial Solutions For Patient Matching Market Report Highlights

Oncology held the largest market share in therapeutic application segment due to rise in cancer cases which are a result of lifestyle changes.

Pharmaceutical companies held the largest market share in the end-use segment, which is a result of increasing drug targeting developments as an initiative of promising recovery.

North America dominated the market and is expected to witness significant growth in the forecast period due to enhancing AI startups. In addition, presence of biopharmaceutical companies and ongoing oncology research to develop therapeutic drugs spur regional growth.

The key players in the market are, Unlearn.AI, Inc.; Antidote Technologies; Inc.; Deep6.ai; Mendel.ai; Aris Global; Deep Lens; AmerisourceBergen Corporation; Koneksa; Microsoft Corporation; GNS Healthcare.

Polaris Market Research has segmented the AI-based clinical trial solutions for patient matching market report based on therapeutic applications, end-use and region:

AI-based Clinical Trial Solutions For Patient Matching, Therapeutic Applications Outlook (Revenue - USD Million, 2022 - 2030)

Oncology

Cardiovascular Diseases

Metabolic Diseases

Neurological Diseases or Conditions

Infectious Diseases

Others

AI-based Clinical Trial Solutions For Patient Matching, End-Use Outlook (Revenue - USD Million, 2022 - 2030)

Pharmaceutical Companies

Academia

Others

AI-based Clinical Trial Solutions For Patient Matching, Regional Outlook (Revenue - USD Million, 2022 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Asia Pacific

Japan

China

India

Australia

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global AI-based Clinical Trial Solutions For Patient Matching Market Insights

  • 4.1. AI-based Clinical Trial Solutions For Patient Matching Market - Industry Snapshot
  • 4.2. AI-based Clinical Trial Solutions For Patient Matching Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in cross-industry alliances and collaborations
      • 4.2.1.2. Rising healthcare data volumes and dataset complexity
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data privacy
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. AI-based Clinical Trial Solutions For Patient Matching Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 5.3. Oncology
    • 5.3.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Oncology, by Region, 2018 - 2030 (USD Million)
  • 5.4. Cardiovascular Diseases
    • 5.4.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Cardiovascular Diseases, by Region, 2018 - 2030 (USD Million)
  • 5.5. Metabolic Diseases
    • 5.5.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Metabolic Diseases, by Region, 2018 - 2030 (USD Million)
  • 5.6. Neurological Diseases or Conditions
    • 5.6.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Neurological Diseases or Conditions, by Region, 2018 - 2030 (USD Million)
  • 5.7. Infectious Diseases
    • 5.7.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Infectious Diseases, by Region, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Others, by Region, 2018 - 2030 (USD Million)

6. Global AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • 6.3. Pharmaceutical Companies
    • 6.3.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Pharmaceutical Companies, by Region, 2018 - 2030 (USD Million)
  • 6.4. Academia
    • 6.4.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Academia, by Region, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Others, by Region, 2018 - 2030 (USD Million)

7. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. AI-based Clinical Trial Solutions For Patient Matching Market Assessment, By Geography, 2018 - 2030 (USD Million)
  • 7.3. AI-based Clinical Trial Solutions For Patient Matching Market - North America
    • 7.3.1. North America: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
    • 7.3.2. North America: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.3.3. AI-based Clinical Trial Solutions For Patient Matching Market - U.S.
      • 7.3.3.1. U.S.: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.3.3.2. U.S.: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.3.4. AI-based Clinical Trial Solutions For Patient Matching Market - Canada
      • 7.3.4.1. Canada: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.3.4.2. Canada: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 7.4. AI-based Clinical Trial Solutions For Patient Matching Market - Europe
    • 7.4.1. Europe: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
    • 7.4.2. Europe: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.3. AI-based Clinical Trial Solutions For Patient Matching Market - UK
      • 7.4.3.1. UK: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.3.2. UK: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.4. AI-based Clinical Trial Solutions For Patient Matching Market - France
      • 7.4.4.1. France: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.4.2. France: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.5. AI-based Clinical Trial Solutions For Patient Matching Market - Germany
      • 7.4.5.1. Germany: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.5.2. Germany: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.6. AI-based Clinical Trial Solutions For Patient Matching Market - Italy
      • 7.4.6.1. Italy: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.6.2. Italy: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.7. AI-based Clinical Trial Solutions For Patient Matching Market - Spain
      • 7.4.7.1. Spain: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.7.2. Spain: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.8. AI-based Clinical Trial Solutions For Patient Matching Market - Netherlands
      • 7.4.8.1. Netherlands: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.8.2. Netherlands: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.9. AI-based Clinical Trial Solutions For Patient Matching Market - Russia
      • 7.4.9.1. Russia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.9.2. Russia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 7.5. AI-based Clinical Trial Solutions For Patient Matching Market - Asia Pacific
    • 7.5.1. Asia Pacific: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
    • 7.5.2. Asia Pacific: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.5.3. AI-based Clinical Trial Solutions For Patient Matching Market - China
      • 7.5.3.1. China: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.5.3.2. China: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.5.4. AI-based Clinical Trial Solutions For Patient Matching Market - India
      • 7.5.4.1. India: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.5.4.2. India: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.5.5. AI-based Clinical Trial Solutions For Patient Matching Market - Malaysia
      • 7.5.5.1. Malaysia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.5.5.2. Malaysia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.5.6. AI-based Clinical Trial Solutions For Patient Matching Market - Japan
      • 7.5.6.1. Japan: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.5.6.2. Japan: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.5.7. AI-based Clinical Trial Solutions For Patient Matching Market - Indonesia
      • 7.5.7.1. Indonesia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.5.7.2. Indonesia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.5.8. AI-based Clinical Trial Solutions For Patient Matching Market - South Korea
      • 7.5.8.1. South Korea: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.5.8.2. South Korea: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 7.6. AI-based Clinical Trial Solutions For Patient Matching Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
    • 7.6.2. Middle East & Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.6.3. AI-based Clinical Trial Solutions For Patient Matching Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.6.3.2. Saudi Arabia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.6.4. AI-based Clinical Trial Solutions For Patient Matching Market - UAE
      • 7.6.4.1. UAE: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.6.4.2. UAE: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.6.5. AI-based Clinical Trial Solutions For Patient Matching Market - Israel
      • 7.6.5.1. Israel: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.6.5.2. Israel: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.6.6. AI-based Clinical Trial Solutions For Patient Matching Market - South Africa
      • 7.6.6.1. South Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.6.6.2. South Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 7.7. AI-based Clinical Trial Solutions For Patient Matching Market - Latin America
    • 7.7.1. Latin America: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
    • 7.7.2. Latin America: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.7.3. AI-based Clinical Trial Solutions For Patient Matching Market - Mexico
      • 7.7.3.1. Mexico: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.7.3.2. Mexico: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.7.4. AI-based Clinical Trial Solutions For Patient Matching Market - Brazil
      • 7.7.4.1. Brazil: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.7.4.2. Brazil: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.7.5. AI-based Clinical Trial Solutions For Patient Matching Market - Argentina
      • 7.7.5.1. Argentina: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.7.5.2. Argentina: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Unlearn.AI, Inc
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Antidote Technologies; Inc
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Deep6.ai
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Mendel.ai
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Aris Global
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Deep Lens
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. AmerisourceBergen Corporation
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Koneksa
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Microsoft Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. GNS Healthcare
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables

  • Table 1 Global AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 2 Global AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 3 AI-based Clinical Trial Solutions For Patient Matching Market Assessment, By Geography, 2018 - 2030 (USD Million)
  • Table 4 North America: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 5 North America: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 6 U.S.: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 7 U.S.: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 8 Canada: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 9 Canada: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 10 Europe: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 11 Europe: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 12 UK: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 13 UK: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 14 France: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 15 France: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 16 Germany: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 17 Germany: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 18 Italy: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 19 Italy: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 20 Spain: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 21 Spain: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 22 Netherlands: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 23 Netherlands: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 24 Russia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 25 Russia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 26 Asia Pacific: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 27 Asia Pacific: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 28 China: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 29 China: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 30 India: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 31 India: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 32 Malaysia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 33 Malaysia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 34 Japan: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 35 Japan: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 36 Indonesia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 37 Indonesia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 38 South Korea: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 39 South Korea: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 40 Middle East & Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 41 Middle East & Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 42 Saudi Arabia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 43 Saudi Arabia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 44 UAE: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 45 UAE: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 46 Israel: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 47 Israel: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 48 South Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 49 South Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 50 Latin America: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 51 Latin America: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 52 Mexico: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 53 Mexico: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 54 Brazil: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 55 Brazil: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 56 Argentina: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 57 Argentina: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)

List of Figures

Figure 1 Global AI-based Clinical Trial Solutions For Patient Matching Market, 2018 - 2030 (USD Million)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top-Down & Bottom-Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by End-Use

Figure 7 Global AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2021 & 2030 (USD Million)

Figure 8 Market by Therapeutic Application

Figure 9 Global AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2021 & 2030 (USD Million)

Figure 10 AI-based Clinical Trial Solutions For Patient Matching Market Assessment, By Geography, 2018 - 2030 (USD Million)

Figure 11 Strategic Analysis - AI-based Clinical Trial Solutions For Patient Matching Market